glp 1 lean mass loss GLP-1 and Muscle Loss: Semaglutide, Tirzepatide & Do GLP-1 medications really cause

Although initially intended for type 2 diabetes, tirzepatide trials have evidenced considerable weight loss impact because the drug triggers both GLP-1 and GIP receptors that reduce hunger and control blood sugar

Genetic predispositions in GLP1R, GIPR, FTO, and MC4R genes may provide context for expected response patterns and personalized dosing strategies

The GLP-1 Receptor Agonist Cardiovascular Therapy market was dominated by North America region in 2025 fueled by the region's high rates of obesity, diabetes, and cardiovascular disorders

Obesity can be caused by unhealthy habits and is often genetic

It's also worth noting that the potential immunological benefits may not require the doses associated with significant weight loss, and therefore come with less side effects (12)

Data on GLP-1 drug coverage is limited in the workers' compensation space